-
Notifications
You must be signed in to change notification settings - Fork 0
/
a.txt
9855 lines (8347 loc) · 149 KB
/
a.txt
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
A A DT B-NP O
Novel Novel NNP I-NP O
Framework Framework NNP I-NP O
to to TO B-VP O
Improve Improve VB I-VP O
siRNA siRNA NN B-NP O
Efficacy Efficacy NN I-NP O
Prediction Prediction NN I-NP O
Bui Bui NNP B-NP O
Thang Thang NNP I-NP O
Ngoc Ngoc NNP I-NP O
Japan Japan NNP B-NP O
Advanced Advanced NNP I-NP O
Institute Institute NNP I-NP O
of of IN B-PP O
Science Science NNP B-NP O
and and CC O O
Technology Technology NNP B-NP O
1-1 1-1 CD B-NP O
Asahidai Asahidai NNP I-NP O
, , , O O
Nomi Nomi NNP B-NP O
City City NNP I-NP O
, , , O O
Ishikawa Ishikawa NNP B-NP O
, , , O O
923-1211 923-1211 CD B-NP O
Japan Japan NNP B-NP O
thangbn thangbn IN B-PP O
@ @ NN B-NP O
jaist.ac.jp jaist.ac.jp NN I-NP O
Abstract. Abstract. NNP B-NP O
Short Short NNP I-NP O
interfering interfere VBG B-VP O
RNA RNA NN B-NP B-DNA
sequences sequence NNS I-NP I-DNA
( ( ( O O
siRNAs siRNA NNS B-NP O
) ) ) O O
can can MD B-VP O
knockdown knockdown VB I-VP O
target target NN B-NP B-DNA
genes gene NNS I-NP I-DNA
and and CC O O
thus thus RB B-ADVP O
have have VBP B-VP O
an an DT B-NP O
immense immense JJ I-NP O
impact impact NN I-NP O
on on IN B-PP O
biology biology NN B-NP O
and and CC I-NP O
pharmacy pharmacy NN I-NP O
research. research. LS B-LST O
The The DT B-NP O
key key JJ I-NP O
question question NN I-NP O
of of IN B-PP O
which which WDT B-NP O
siRNAs siRNA NNS B-NP B-RNA
have have VBP B-VP O
high high JJ B-NP O
knockdown knockdown NN I-NP O
ability ability NN I-NP O
in in IN B-PP O
siRNA siRNA NN B-NP O
research research NN I-NP O
remains remain VBZ B-VP O
challenging challenging JJ B-ADJP O
as as IN B-PP O
current current JJ B-NP O
known know VBN I-NP O
results result NNS I-NP O
are be VBP B-VP O
still still RB B-ADVP O
far far RB B-ADVP O
from from IN B-PP O
expectation. expectation. FW B-ADJP O
This This DT B-NP O
work work NN I-NP O
aims aim VBZ B-VP O
to to TO I-VP O
develop develop VB I-VP O
a a DT B-NP O
generic generic JJ I-NP O
framework framework NN I-NP O
to to TO B-PP O
enhance enhance VB B-VP O
siRNA siRNA NN B-NP O
knockdown knockdown NN I-NP O
efficacy efficacy NN I-NP O
prediction. prediction. VBP B-VP O
The The DT B-NP O
key key JJ I-NP O
idea idea NN I-NP O
is be VBZ B-VP O
first first VBN I-VP O
to to TO B-PP O
enrich enrich JJ B-NP O
siRNA siRNA NN I-NP O
sequences sequence NNS I-NP O
by by IN B-PP O
incorporating incorporate VBG B-VP O
them them PRP B-NP O
with with IN B-PP O
rules rule NNS B-NP O
found find VBN B-VP O
for for IN B-PP O
de- de- NN B-NP O
signing sign VBG B-VP O
effective effective JJ B-NP O
siRNAs siRNA NNS I-NP O
and and CC O O
representing represent VBG B-VP O
them them PRP B-NP O
as as IN B-PP O
transformed transform VBN B-NP O
matrices matrix NNS I-NP O
, , , O O
then then RB B-ADVP O
to to TO B-VP O
employ employ VB I-VP O
the the DT B-NP O
bilinear bilinear JJ I-NP O
tensor tensor NN I-NP O
regression regression NN I-NP O
to to TO B-VP O
do do VB I-VP O
prediction prediction NN B-NP O
on on IN B-PP O
those those DT B-NP O
matrices. matrices. NN B-NP O
Experiments Experiment NNS I-NP O
show show VBP B-VP O
that that IN B-SBAR O
the the DT B-NP O
proposed propose VBN I-NP O
method method NN I-NP O
achieves achieve VBZ B-VP O
results result NNS B-NP O
better well RBR B-ADVP O
than than IN B-PP O
existing exist VBG B-NP O
models model NNS I-NP O
in in IN B-PP O
most most JJS B-NP O
cases case NNS I-NP O
. . . O O
1 1 CD B-NP O
Introduction Introduction NN B-NP O
In In IN B-PP O
2006 2006 CD B-NP O
, , , O O
Fire Fire NNP B-NP O
and and CC I-NP O
Mello Mello NNP I-NP O
received receive VBD B-VP O
their their PRP$ B-NP O
Nobel Nobel NNP I-NP O
Prize Prize NNP I-NP O
for for IN B-PP O
their their PRP$ B-NP O
contributions contribution NNS I-NP O
to to TO B-PP O
research research NN B-NP O
on on IN B-PP O
RNA RNA NN B-NP O
interference interference NN I-NP O
( ( ( O O
RNAi RNAi NN B-NP B-protein
) ) ) O O
that that WDT B-NP O
is be VBZ B-VP O
the the DT B-NP O
biological biological JJ I-NP O
process process NN I-NP O
in in IN B-PP O
which which WDT B-NP O
RNA RNA NN B-NP B-protein
molecules molecule NNS I-NP I-protein
inhibit inhibit VBP B-VP O
gene gene NN B-NP O
expression expression NN I-NP O
, , , O O
typically typically RB B-ADVP O
by by IN B-PP O
causing cause VBG B-VP O
the the DT B-NP O
destruction destruction NN I-NP O
of of IN B-PP O
specific specific NN B-NP O
mRNA mRNA NN I-NP O
molecules. molecules. NN I-NP O
Their Their PRP$ B-NP O
work work NN I-NP O
and and CC O O
that that DT O O
of of IN B-PP O
others other NNS B-NP O
on on IN B-PP O
discovery discovery NN B-NP O
of of IN B-PP O
RNAi RNAi NN B-NP O
have have VB B-VP O
had have VBN I-VP O
an an DT B-NP O
immense immense JJ I-NP O
impact impact NN I-NP O
on on IN B-PP O
biomedical biomedical JJ B-NP O
research research NN I-NP O
and and CC O O
will will MD B-VP O
most most RBS B-ADVP O
likely likely RB I-ADVP O
lead lead VBP B-VP O
to to TO B-PP O
novel novel JJ B-NP O
medical medical JJ I-NP O
applications. applications. NN I-NP O
On On IN B-PP O
RNAi RNAi NNP B-NP O
research research NN I-NP O
, , , O O
designing design VBG B-VP O
of of IN B-PP O
siRNAs siRNA NNS B-NP O
( ( ( O O
short short JJ O O
interfering interfere VBG B-NP B-RNA
RNAs RNA NNS I-NP I-RNA
) ) ) O O
with with IN B-PP O
high high JJ B-NP O
efficacy efficacy NN I-NP O
is be VBZ B-VP O
one one CD B-NP O
of of IN B-PP O
the the DT B-NP O
most most RBS I-NP O
crucial crucial JJ I-NP O
RNAi RNAi NNP I-NP O
issues issue NNS I-NP O
. . . O O
Highly Highly RB B-NP O
effective effective JJ I-NP B-RNA
siRNAs siRNA NNS I-NP I-RNA
can can MD B-VP O
be be VB I-VP O
used use VBN I-VP O
to to TO B-VP O
design design VB I-VP O
drugs drug NNS B-NP O
for for IN B-PP O
viral-mediated viral-mediated JJ B-NP O
diseases disease NNS I-NP O
such such JJ B-PP O
as as IN I-PP O
Influenza Influenza NN B-NP O
A A NN I-NP O
virus virus NN I-NP O
, , , O O
HIV HIV NN B-NP O
, , , O O
Hepatitis Hepatitis NN B-NP O
B B NN I-NP O
virus virus NN I-NP O
, , , O O
RSV RSV NN B-NP O
viruses virus NNS I-NP O
, , , O O
cancer cancer NN B-NP O
disease disease NN I-NP O
and and CC O O
so so RB B-ADVP O
on. on. RB I-ADVP O
As As IN B-PP O
a a DT B-NP O
result result NN I-NP O
, , , O O
siRNA siRNA NN B-NP O
silencing silencing NN I-NP O
is be VBZ B-VP O
considered consider VBN I-VP O
one one CD B-NP O
of of IN B-PP O
the the DT B-NP O
most most RBS I-NP O
promising promising JJ I-NP O
techniques technique NNS B-NP O
in in IN B-PP O
future future JJ B-NP O
therapy. therapy. NN I-NP O
Finding Find VBG B-VP O
highly highly RB B-NP O
effective effective JJ I-NP O
siRNAs siRNA NNS I-NP O
among among IN B-PP O
thousands thousand NNS B-NP O
of of IN B-PP O
potential potential JJ B-NP O
siRNAs siRNA NNS I-NP O
for for IN B-PP O
an an DT B-NP O
mRNA mRNA NN I-NP B-RNA
remains remain VBZ B-VP O
a a DT B-NP O
great great JJ I-NP O
challenge challenge NN I-NP O
. . . O O
Various Various JJ B-NP O
siRNA siRNA NN I-NP O
design design NN I-NP O
rules rule NNS I-NP O
have have VBP B-VP O
been be VBN I-VP O
found find VBN I-VP O
by by IN B-PP O
empirical empirical JJ B-NP O
processes process NNS I-NP O
since since IN B-PP O
1998 1998 CD B-NP O
. . . O O
The The DT B-NP O
first first RBS I-NP O
rational rational JJ I-NP O
siRNA siRNA NN I-NP O
design design NN I-NP O
rule rule NN I-NP O
was be VBD B-VP O
detected detect VBN I-VP O
by by IN B-PP O
Elibalshir Elibalshir NNP B-NP O
et et FW I-NP O
al. al. FW I-NP O
[ [ ( O O
2 2 CD B-NP O
] ] ) O O
. . . O O
They They PRP B-NP O
suggested suggest VBD B-VP O
that that IN B-SBAR O
siRNAs siRNA NNS B-NP O
having have VBG B-VP O
19–21 19–21 CD B-NP O
nt nt NN I-NP O
( ( ( O O
nucleotide nucleotide NN B-NP O
) ) ) O O
in in IN B-PP O
length length NN B-NP O
with with IN B-PP O
2 2 CD B-NP O
nt nt NN I-NP O
over- over- NN I-NP O
hangs hang NNS B-NP O
at at IN B-PP O
3’ 3’ NN B-NP O
end end NN I-NP O
can can MD B-VP O
efficiently efficiently RB I-VP O
silence silence VB I-VP O
mRNAs. mRNAs. NNP B-NP O
Scherer Scherer NNP I-NP O
et et FW I-NP O
al. al. FW I-NP O
reported report VBD B-VP O
that that IN B-SBAR O
the the DT B-NP O
thermodynamic thermodynamic JJ B-NP O
properties property NNS I-NP O
( ( ( O O
G/C G/C NN B-NP O
content content NN I-NP O
of of IN B-PP O
siRNA siRNA NN B-NP O
) ) ) O O
to to TO B-VP O
target target VB I-VP O
specific specific NN B-NP B-RNA
mRNAs mRNA NNS I-NP I-RNA
are be VBP O O
important important JJ B-NP O
characteristics characteristic NNS I-NP O
[ [ ( O O
11 11 CD B-NP O
] ] ) O O
. . . O O
Soon Soon RB B-ADVP O
after after IN B-PP O
these these DT B-NP O
works work NNS I-NP O
, , , O O
many many JJ B-NP O
rational rational JJ I-NP O
design design NN I-NP O
rules rule NNS B-NP O
for for IN B-PP O
effective effective JJ B-NP B-RNA
siRNAs siRNA NNS I-NP I-RNA
have have VBP B-VP O
been be VBN I-VP O
found find VBN I-VP O
, , , O O
typically typically RB B-NP O
those those DT I-NP O
in in IN B-PP O
[ [ ( O O
10 10 CD B-NP O
] ] ) O O
, , , O O
[ [ ( O O
15 15 CD B-NP O
] ] ) O O
, , , O O
[ [ ( O O
1 1 CD B-NP O
] ] ) O O
, , , O O
[ [ ( O O
4 4 CD B-NP O
] ] ) O O
, , , O O
[ [ ( O O
7 7 CD B-NP O
] ] ) O O
, , , O O
[ [ ( O O
14 14 CD B-NP O
] ] ) O O
. . . O O
For For IN B-PP O
example example NN B-NP O
, , , O O
Reynolds Reynolds NNP B-NP O
et et FW I-NP O
al. al. FW I-NP O
[ [ ( O O
10 10 CD B-NP O
] ] ) O B-RNA
analyzed analyze VBD B-VP I-RNA
180 180 CD B-NP I-RNA
siRNAs siRNA NNS I-NP I-RNA
and and CC O O
found find VBD B-VP O
eight eight CD B-NP O
criteria criterion NNS B-NP O
for for IN B-PP O
improving improve VBG B-VP O
siRNA siRNA NN B-NP O
selection selection NN I-NP O
: : : O O
( ( ( B-LST O
1 1 LS I-LST O
) ) ) O O
G/C G/C NN B-NP O
content content NN I-NP O
30−52 30−52 CD B-NP O
% % NN I-NP O
, , , O O
( ( ( B-LST O
2 2 LS I-LST O
) ) ) O O
at at IN B-NP O
least least JJS I-NP O
3 3 CD I-NP O
V.S. V.S. NNP B-NP O
Tseng Tseng NNP I-NP O
et et FW I-NP O
al. al. FW I-NP O
( ( ( O O
Eds. Eds. NNP B-NP O
) ) ) O O
: : : O O
PAKDD PAKDD NN B-NP O
2014 2014 CD I-NP O
, , , O O
Part Part NNP B-NP O
II II NNP I-NP O
, , , O O
LNAI LNAI NNP B-NP O
8444 8444 CD I-NP O
, , , O O
pp. pp. NN B-NP B-protein
400–412 400–412 CD I-NP I-protein
, , , I-NP O
2014 2014 CD I-NP O
. . . O O
c c NN B-NP O
( ( ( O O
cid cid NN B-NP O
: : : O O
2 2 LS B-LST O
) ) ) O O
Springer Springer NNP B-NP O
International International NNP I-NP O
Publishing Publishing NNP I-NP O
Switzerland Switzerland NNP I-NP O
2014 2014 CD I-NP O
A A DT B-NP O
Novel Novel NNP I-NP O
Framework Framework NNP I-NP O
to to TO B-VP O
Improve Improve VB I-VP O
siRNA siRNA NN B-NP O
Efficacy Efficacy NN I-NP O
Prediction Prediction NN I-NP O
401 401 CD B-NP O
As As IN B-SBAR O
or or CC O O
Us U NNS B-NP O
at at IN B-PP O
positions position NNS B-NP O
from from IN B-PP O
15 15 CD B-NP O
to to TO B-PP O
19 19 CD B-NP O
, , , O O
( ( ( B-LST O
3 3 LS I-LST O
) ) ) O O
absence absence NN B-NP O
of of IN B-PP O
internal internal JJ B-NP B-DNA
repeats repeat NNS I-NP I-DNA
, , , O O
( ( ( B-LST O
4 4 LS I-LST O
) ) ) O O
an an DT B-NP O
A A NN I-NP O
at at IN B-PP O
position position NN B-NP B-protein
19 19 CD I-NP I-protein
, , , O O
( ( ( B-LST O
5 5 LS I-LST O
) ) ) O O
an an DT B-NP O
A A NN I-NP O
at at IN B-PP O
position position NN B-NP B-protein
3 3 CD I-NP I-protein
, , , O O
( ( ( O O
6 6 CD B-NP O
) ) ) O O
a a DT B-NP O
U U NN I-NP O
at at IN B-PP O
position position NN B-NP B-protein
10 10 CD I-NP I-protein
, , , O O
( ( ( O O
7 7 CD B-NP O
) ) ) O O
a a DT B-NP O
base base NN I-NP O
other other JJ B-ADJP O
than than IN B-SBAR O
G G NN B-NP O
or or CC I-NP O
C C NN I-NP O
at at IN B-PP O
position position NN B-NP B-protein
19 19 CD I-NP I-protein
, , , O O
( ( ( O O
8 8 CD B-NP O
) ) ) O O
a a DT B-NP O
base base NN I-NP O
other other JJ B-ADJP O
than than IN B-PP O
G G NN B-NP O
at at IN B-PP O
position position NN B-NP B-protein
13 13 CD I-NP I-protein
. . . O O
However However RB B-ADVP O
, , , O O
most most JJS B-NP O
of of IN B-PP O
siRNA siRNA NN B-NP O
design design NN I-NP O
tools tool NNS I-NP O
using use VBG B-VP O
the the DT B-NP O
above-mentioned above-mentioned JJ I-NP O
design design NN I-NP O
rules rule NNS I-NP O
have have VB B-VP O
low low JJ B-NP O
accuracy accuracy NN I-NP O
, , , O O
because because IN B-SBAR O
about about IN B-NP O
65 65 CD I-NP O
% % NN I-NP O
of of IN B-PP O
the the DT B-NP O
siRNAs siRNA NNS I-NP O
predicted predict VBN B-VP O
as as IN B-PP O
high high JJ B-NP O
effective effective JJ I-NP O
was be VBD B-VP O
failed fail VBN I-VP O
when when WRB B-ADVP O
tested test VBN B-VP O
experimentally experimentally RB B-ADVP O
as as IN B-SBAR O
they they PRP B-NP O
were be VBD B-VP O
90 90 CD B-NP O
% % NN I-NP O
in in IN B-PP O
inhibition inhibition NN B-NP O
and and CC O O
near near IN O O
20 20 CD B-NP O
% % NN I-NP O
of of IN B-PP O
them them PRP B-NP O
were be VBD B-VP O
found find VBN I-VP O
to to TO I-VP O
be be VB I-VP O
inactive inactive JJ B-ADJP O
[ [ ( O O
9 9 CD B-NP O
] ] ) O O
. . . O O
One One CD B-NP O
reason reason NN I-NP O
is be VBZ B-VP O
the the DT B-NP O
previous previous JJ I-NP O
empirical empirical JJ I-NP O
analyses analysis NNS B-NP O
only only RB B-VP O
based base VBN I-VP O
on on IN B-PP O
small small JJ B-NP O
datasets dataset NNS I-NP O
and and CC O O
focused focus VBD B-VP O
on on IN B-PP O
specific specific NN B-NP O
genes. genes. NN I-NP O
Therefore Therefore RB B-ADVP O
, , , O O
each each DT B-NP O
of of IN B-PP O
these these DT B-NP O
rules rule NNS I-NP O
certainly certainly RB B-ADVP O
is be VBZ B-VP O
poor poor JJ B-ADJP O
to to TO B-VP O
individually individually RB I-VP O
design design VB I-VP O
effective effective JJ B-NP B-RNA
siRNAs siRNA NNS I-NP I-RNA
. . . O O
Since Since IN B-PP O
nearly nearly RB B-NP O
a a DT I-NP O
decade decade NN I-NP O
, , , O O
machine machine NN B-NP O
learning learning NN I-NP O
techniques technique NNS I-NP O
have have VBP B-VP O
alternatively alternatively RB I-VP O
been be VBN I-VP O
applied apply VBN B-VP O
to to TO B-VP O
predict predict VB I-VP O
knockdown knockdown JJ B-NP O
efficacy efficacy NN I-NP O
of of IN B-PP O
siRNAs. siRNAs. NN B-NP O
The The DT B-NP O
first first RBS I-NP O
predictive predictive JJ I-NP O
model model NN I-NP O
was be VBD B-VP O
proposed propose VBN B-VP O
by by IN B-PP O
Huesken Huesken NNP B-NP O
et et FW I-NP O
al. al. FW I-NP O
in in IN B-PP O
which which WDT B-NP O
motifs motif NNS B-NP O
for for IN B-PP O
effective effective JJ B-NP O
and and CC I-NP O
ineffective ineffective JJ I-NP B-protein
siRNA siRNA NN I-NP I-protein
se- se- NN I-NP I-protein
quences quence NNS B-NP O
were be VBD B-VP O
detected detect VBN I-VP O
basing base VBG B-VP O
on on IN B-PP O
the the DT B-NP O
significance significance NN I-NP O
of of IN B-PP O
nucleotides nucleotide NNS B-NP O
by by IN B-PP O
using use VBG B-VP O
a a DT B-NP O
neural neural JJ I-NP O
network network NN B-NP O
to to TO B-PP O
train train NN B-NP B-protein
2 2 CD I-NP I-protein
, , , I-NP O
182 182 CD I-NP O
scoring score VBG I-NP O
siRNAs siRNA NNS I-NP O
( ( ( O O
scores score NNS B-NP O
are be VBP B-VP O
real real JJ B-NP O
numbers number NNS I-NP O
in in IN B-PP O
[ [ ( B-NP O
0 0 CD I-NP O
, , , I-NP O
1 1 CD I-NP O
] ] ) O O
, , , O O
the the DT B-NP O
high high JJ I-NP O
score score VBP B-VP O
the the DT B-NP O
higher high JJR I-NP O
knockdown knockdown JJ I-NP O
efficacy efficacy NN I-NP O
) ) ) O O
and and CC O O
test test NN B-NP O
on on IN B-PP O
249 249 CD B-NP B-RNA
siRNAs siRNA NNS I-NP I-RNA
[ [ ( O O
5 5 CD B-NP O
] ] ) O O
. . . O O
This This DT B-NP O
data datum NNS I-NP O
set set VBD B-VP O
was be VBD B-VP O
consequently consequently RB I-VP O
used use VBN I-VP O
to to TO B-VP O
build build VB I-VP O
other other JJ B-NP O
predictive predictive JJ I-NP O
models model NNS I-NP O
[ [ ( O O
6 6 CD B-NP O
] ] ) O O
, , , O O
[ [ ( O O
13 13 CD B-NP O
] ] ) O O
, , , O O
[ [ ( O O
16 16 CD B-NP O
] ] ) O O
. . . O O
Recently Recently RB B-ADVP O
, , , O O
Qui Qui NNP B-NP O
et et FW I-NP O
al. al. FW I-NP O
used use VBN B-VP O
multiple multiple JJ B-NP O
support support NN I-NP O
vector vector NN I-NP O
regression regression NN I-NP O
with with IN B-PP O
RNA RNA NN B-NP O
string string VBG B-VP O
kernel kernel NN B-NP O
for for IN B-PP O
siRNA siRNA NN B-NP O
efficacy efficacy NN I-NP O
prediction prediction NN I-NP O
[ [ ( O O
8 8 CD B-NP O
] ] ) O O
, , , O O
and and CC O O
Sciabola Sciabola NNP B-NP O
et et FW I-NP O
al. al. FW I-NP O
applied apply VBD B-VP O
three three CD B-NP O
dimension dimension NN I-NP O
struc- struc- NN I-NP O
tural tural JJ B-NP O
information information NN I-NP O
of of IN B-PP O
siRNA siRNA NN B-NP O
to to TO B-VP O
increase increase VB I-VP O
predictability predictability NN B-NP O
of of IN B-PP O
the the DT B-NP O
regression regression NN I-NP O
model model NN I-NP O
[ [ ( O O
12 12 CD B-NP O
] ] ) O O
. . . O O
However However RB B-ADVP O
, , , O O
most most JJS B-NP O
of of IN B-PP O
those those DT B-NP O
methods method NNS I-NP O
suffer suffer NN I-NP O
from from IN B-PP O
some some DT B-NP O
drawbacks. drawbacks. FW I-NP O
Their Their PRP$ B-NP O
correlations correlation NNS I-NP O
between between IN B-PP O
predicted predict VBN B-NP O
values value NNS I-NP O
and and CC O O
experimental experimental JJ B-NP O
values value NNS I-NP O
of of IN B-PP O
dependent dependent JJ B-NP O
variable variable NN I-NP O
ranging range VBG B-VP O
from from IN B-PP O
0.60 0.60 CD B-NP O
to to TO B-PP O
0.68 0.68 CD B-NP O
were be VBD B-VP O
considerably considerably RB I-VP O
decreased decrease VBN I-VP O
when when WRB B-ADVP O
testing test VBG B-VP O
on on IN B-PP O
independent independent JJ B-NP O
data datum NNS I-NP O
sets. sets. LS B-LST O
It It PRP B-NP O
may may MD B-VP O
be be VB I-VP O
caused cause VBN I-VP O
by by IN B-PP O
the the DT B-NP O
fact fact NN I-NP O
that that IN B-SBAR O
the the DT B-NP O
Huesken Huesken NNP I-NP O
dataset dataset NN I-NP O
may may MD B-VP O
not not RB I-VP O
be be VB I-VP O
repre- repre- NN B-NP O
sentative sentative JJ B-NP O
of of IN B-PP O
the the DT B-NP O
siRNA siRNA NN I-NP O
population population NN I-NP O
having have VBG B-VP O
about about IN B-NP O
419 419 CD I-NP B-RNA
siRNAs siRNA NNS I-NP I-RNA
and and CC O O
the the DT B-NP O
sample sample NN I-NP O
size size NN I-NP O
is be VBZ B-VP O
small. small. JJ B-ADJP O
Besides Besides IN B-PP O
the the DT B-NP O
scoring score VBG I-NP O
siRNA siRNA NN I-NP O
dataset dataset NN I-NP O
, , , O O
the the DT B-NP O
labelled label VBN I-NP O
siRNA siRNA NN I-NP O
datasets dataset NNS I-NP O
, , , O O
e.g e.g NN B-NP O
. . . O O
siRecord siRecord NN B-NP O
database database NN I-NP O
[ [ ( O O
9 9 CD B-NP O
] ] ) O O
with with IN B-PP O
labels label NNS B-NP O
such such JJ B-PP O
as as IN I-PP O
‘very ‘very JJ B-NP O
high” high” NN I-NP O
, , , O O
‘high’ ‘high’ NN B-NP O
, , , O O
‘medium’ ‘medium’ NN B-NP O
, , , O O
‘low’ ‘low’ NN B-NP B-protein
for for IN B-PP O